Stock analysts at Wolfe Research began coverage on shares of Tempus AI (NASDAQ:TEM - Get Free Report) in a research report issued to clients and investors on Friday, MarketBeat reports. The firm set an "outperform" rating and a $60.00 price target on the stock. Wolfe Research's price objective suggests a potential upside of 46.34% from the company's previous close.
Other analysts have also recently issued reports about the stock. Bank of America cut shares of Tempus AI from a "buy" rating to a "neutral" rating and upped their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Piper Sandler reaffirmed a "neutral" rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a report on Monday. They set a "buy" rating and a $74.00 target price on the stock. Loop Capital upped their price target on Tempus AI from $48.00 to $57.00 and gave the stock a "buy" rating in a report on Tuesday, October 15th. Finally, Stifel Nicolaus downgraded shares of Tempus AI from a "buy" rating to a "hold" rating and increased their price objective for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $56.00.
Read Our Latest Stock Report on Tempus AI
Tempus AI Trading Down 2.4 %
Shares of TEM stock traded down $0.99 on Friday, reaching $41.00. 5,041,241 shares of the stock were exchanged, compared to its average volume of 1,427,998. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The stock's 50 day moving average price is $52.88. Tempus AI has a 1-year low of $22.89 and a 1-year high of $79.49.
Insider Buying and Selling at Tempus AI
In other news, major shareholder Bradley A. Keywell sold 395,800 shares of Tempus AI stock in a transaction dated Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total value of $16,999,610.00. Following the completion of the transaction, the insider now directly owns 16,164,449 shares of the company's stock, valued at approximately $694,263,084.55. The trade was a 2.39 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, COO Ryan Fukushima sold 120,000 shares of the company's stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $42.51, for a total value of $5,101,200.00. Following the transaction, the chief operating officer now owns 1,007,207 shares of the company's stock, valued at approximately $42,816,369.57. The trade was a 10.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 650,949 shares of company stock worth $27,821,944 in the last ninety days.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in TEM. Franklin Resources Inc. increased its stake in shares of Tempus AI by 1.0% during the third quarter. Franklin Resources Inc. now owns 811,311 shares of the company's stock valued at $45,920,000 after acquiring an additional 8,387 shares during the period. Tidal Investments LLC bought a new position in Tempus AI during the 3rd quarter valued at $7,633,000. Teachers Retirement System of The State of Kentucky lifted its holdings in shares of Tempus AI by 6.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company's stock valued at $7,160,000 after buying an additional 7,500 shares during the period. Geode Capital Management LLC boosted its position in shares of Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company's stock valued at $7,537,000 after purchasing an additional 539 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Tempus AI in the 3rd quarter worth approximately $502,000. Institutional investors and hedge funds own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
